gene editing

Knowledge of the powerful functional T-cell drivers can give complex engineered immune cell therapies the edge they need

Polyfunctional Strength Index (PSI™) detects the highly polyfunctional cell subsets, typically missed in bulk, that correlate to in vivo outcome in cell therapy. Isolating these differences helps you understand how to engineer the potency and durability needed throughout development & bioprocessing.

gene editing

See What’s Next in Cell Therapy

Explore by Cell Engineering & Therapy Development

Explore by Cell Therapies and Cell Types

“Only by pairing product data with clinical outcomes will commercial application of CAR T cells be further optimized and support enhanced safety and efficacy for patients.”

Blood Commentary

Discover. Optimize. Predict.

IsoPlexis is empowering Cell Therapy development across the discover-optimize-predict continuum

Discover Differences

Detect the small potent cell subsets that make the difference

Discover cellular potency differences resulting in post CRISPR gene edits to NK cells

Follow Our Data

Optimize Bioprocessing

Optimize potency in cell therapy bioprocessing by revealing the differences

Identify methodologies for increasing potency in cell therapy bioprocessing

Follow Our Data

Predict Response

Correlate data with response to predict clinical outcome

Predict in vivo outcome & stratify response with pre-infusion cell therapy product (PSI™) metric

Follow Our Data

Explore Resources

Identify the Most Potent Cell Subsets in Your Samples

Our award-winning, single-cell system effortlessly delivers the data you need.

See How